• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Office of Scientific Integrity

 

Formed in 2009, the Office of Scientific Integrity (OSI) reports to the Chief Scientist and works with the Office of the Commissioner and FDA's other Centers to:

  1. ensure that FDA's policies and procedures concerning scientific integrity at FDA are current and applied across the Agency; and
  2. review and work to resolve both informal and formal scientific disputes.

OSI evaluates scientific differences that are not resolved at Center levels and advises the Chief Scientist and other senior FDA leaders on appropriate responses. OSI coordinates FDA’s response to and evaluation of allegations of improper deviation from established procedures governing FDA’s regulatory mandate. This includes review of pre- and post-market decisions, food-related issues, enforcement actions, and congressional obligations. Through the ombudsman function, OSI reviews and facilitates the resolution of complaints and disagreements, generated internally or externally, on the fair application of policies and procedures. 

Major Functions

  • Develops and implements policies to promote and protect scientific integrity throughout all of FDA’s activities and organizational components.
  • Helps ensure consistent understanding, application and implementation of regulatory standards throughout FDA to ensure integrity and accountability of FDA functions and processes
  • Provides advice and guidance to the Commissioner, Chief Scientist, and other key officials regarding premarket approval processes for all FDA-regulated products including requirements pertaining to applications, petitions, amendments and supplements; and product, processing, packaging and emerging product technologies
  • Advises and assists senior FDA leadership in coordinating responses to allegations of patterns of deviations by FDA or its components from appropriate standards of conduct and performance. Also advises and assists senior FDA leadership in preventing such deviations
  • Investigates and facilitates resolution of informal complaints and disagreements, whether generated internally or externally, with respect to the administrative processing of various applications for products regulated by the agency as well as regarding the fair and even-handed application of agency policy and procedures in this process
  • Processes all formal appeals, or requests for review, that are submitted to the Office of the Commissioner, whether generated internally or externally, including requests for hearings, appeals from administrative actions, and requests to review decisions at a lower level of the agency.  Examples include, but are not limited to, requests to review decisions by the Centers, the Office of Regulatory Affairs, and elsewhere in the Office of the Commissioner under 21 CFR 10.75, appeals of formal or informal hearings, and agency-level scientific dispute resolution matters
  • Advises and assists the Chief Scientist and senior leadership in evaluating and resolving all formal appeals, requests for review, and requests for hearings submitted to the Office of the Commissioner and coordinates responses to such appeals and requests
  • Develops regulations and procedures to promote an efficient and effective process for addressing and resolving formal appeals, requests for review, and requests for hearings, as well as any other types of disputes suitable for formal resolution in the Office of the Commissioner
  • Determines whether an informal complaint should be construed and treated as a request for formal review by the Office of the Commissioner under established regulations or procedures
  • Oversees and directs the agency’s ombudsman and appeals to ensure coherence in decision making and the efficient operation of these functions internally and across the agency